http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10872060

Outgoing Links

Predicate Object
contentType Journal Article|Multicenter Study
endingPage 2956
issn 0171-5216
1432-1335
issueIdentifier 11
pageRange 2949-2956
publicationName Journal of Cancer Research and Clinical Oncology
startingPage 2949
bibliographicCitation Kudo A, Shinoda M, Ariizumi S, Kumamoto T, Katayama M, Otsubo T, Endo I, Kitagawa Y, Tanabe M, Yamamoto M; Association for Clinical Research on Surgery Group. Des-gamma-carboxy prothrombin affects the survival of HCC patients with marginal liver function and curative treatment: ACRoS1402. J Cancer Res Clin Oncol. 2020 Nov;146(11):2949–56. doi: 10.1007/s00432-020-03270-2. PMID: 32462296.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd1cc27ed7f873d518c0049305dc51c5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_066035314274565dfc2ef2a3cff7d4c8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4cc485cc0cbeb3e58ef95939e2212eb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8801d58e3bbc4b3193f27323a0dbf442
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac8a6eefc75344d04f42c4dc5aa071be
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f84425469f3f1e1e91041b4b2a704b8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cdd197e76ec220766914287e9ed326a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9865d813c4e31030e1ded2fccdefd182
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5301-3847
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a18b8985d1565755640a32cb2b93eb73
date 2020-05-27^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/32462296
https://doi.org/10.1007/s00432-020-03270-2
isPartOf https://portal.issn.org/resource/ISSN/0171-5216
https://portal.issn.org/resource/ISSN/1432-1335
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4574
language English
source https://scigraph.springernature.com/
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Des-gamma-carboxy prothrombin affects the survival of HCC patients with marginal liver function and curative treatment: ACRoS1402
discusses http://id.nlm.nih.gov/mesh/M0017904
http://id.nlm.nih.gov/mesh/M0023752
http://id.nlm.nih.gov/mesh/M0051859
http://id.nlm.nih.gov/mesh/M0022149
http://id.nlm.nih.gov/mesh/M0017873
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D014408Q000097
http://id.nlm.nih.gov/mesh/D011498Q000097
http://id.nlm.nih.gov/mesh/D006528Q000097
http://id.nlm.nih.gov/mesh/D008113Q000097
http://id.nlm.nih.gov/mesh/D015415Q000097
hasSubjectTerm http://id.nlm.nih.gov/mesh/D018572
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008113Q000401
http://id.nlm.nih.gov/mesh/D011516
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D006528Q000401
http://id.nlm.nih.gov/mesh/D008113Q000628
http://id.nlm.nih.gov/mesh/D006528Q000628
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132274068
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284572
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7992
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19190
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fadc3c8509db129e10ef4cfccf6efc5d
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92132757
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_95d926625e5919a35cb6aa367ba7b069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165411817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11967809
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8345

Showing number of triples: 1 to 65 of 65.